Work

Poster: MM-361 The Prognostic Role and Utility of Highly Sensitive Minimal Residual Disease Assay in Multiple Myeloma: Is There Really a Difference?

Year: 2022

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(22)01124-7

Authors: Rodrigo Fonseca, Julia E. Wiedmeier, Mariano Arribas N/A, Rafael Fonseca

Institution: Mayo Clinic Hospital

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4296613317

FWCI:

Cites:

Cited by:

Related to: 10